Mr Jose Antonio Rodriguez, in Moreno Valley, CA - Social Worker

Mr Jose Antonio Rodriguez, is a Social Worker - Clinical based in Moreno Valley, California. Mr Jose Antonio Rodriguez is licensed to practice in California (license number LCSW94079) and his current practice location is 12625 Heacock St, Moreno Valley, California. He can be reached at his office (for appointments etc.) via phone at (951) 486-7948.

NPI number for Mr Jose Antonio Rodriguez is 1033585021 and his current mailing address is 12625 Heacock St, Moreno Valley, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1033585021.

Contact Information

	Mr Jose Antonio Rodriguez,
	12625 Heacock St, Moreno Valley, CA 92553-0538
	(951) 486-7948
	Not Available

Healthcare Provider's Profile

Full Name	Mr Jose Antonio Rodriguez
Gender	Male
Speciality	Social Worker - Clinical
Location	12625 Heacock St, Moreno Valley, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1033585021
Provider Enumeration Date: 08/13/2015
Last Update Date: 05/18/2021

Medical Identifiers

Medical identifiers for Mr Jose Antonio Rodriguez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033585021	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	72189 (California)	Secondary
225400000X	Rehabilitation Practitioner	(* (Not Available))	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Secondary
1041C0700X	Social Worker - Clinical	LCSW94079 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Jose Antonio Rodriguez is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Jose Antonio Rodriguez, 12625 Heacock St, Moreno Valley, CA 92553-0538 Ph: (951) 486-7948	Mr Jose Antonio Rodriguez, 12625 Heacock St, Moreno Valley, CA 92553-0538 Ph: (951) 486-7948

News Archive

Sensofar, the Leading-Edge Technology Group within the Surface Optical Metrology Field, Celebrates 20 Years of Business

2021 is a year of celebration for Sensofar, we have been in business for 20 years. Our beginning was enhanced by the passionate and entrepreneurial spirit of our founders, when they wanted to leverage their knowledge about the science of light, to create disruptive technologies that would demonstrate to the market the need for and benefits of optical metrology. Their passion for science became the core of the business.

First high-resolution images of the earliest stages of bone formation

Researchers at Eindhoven University of Technology (TU/e) have for the first time made high-resolution images of the earliest stages of bone formation.

UTMB scientists receive access to research materials with efforts from TIGM

Texas A&M Institute for Genomic Medicine (TIGM) – a research institute of the Texas A&M Health Science Center – has created a grant-in-aid program specifically to assist University of Texas Medical Branch at Galveston (UTMB) scientists obtain access to research materials in an effort to help speed the recovery of UTMB's research programs from some of the injuries caused by Hurricane Ike.

Endo International announces pricing of $1.635 billion aggregate principal amount of 6.00% senior notes

Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal acute myeloid leukemia, or CN-AML).

Mr Jose Antonio Rodriguez, - Counselor in Moreno Valley, CA